Low Dose Ketoconazole With Replacement Doses of Hydrocortisone in Patients With Progressive Androgen Independent Prostate Cancer
- 1 August 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 168 (2) , 542-545
- https://doi.org/10.1016/s0022-5347(05)64675-7
Abstract
Conclusions The regimen of low dose ketoconazole with replacement doses of hydrocortisone is well tolerated and has moderate activity in patients with progressive androgen independent prostate cancer.Keywords
This publication has 17 references indexed in Scilit:
- Simultaneous antiandrogen withdrawal and treatment with ketoconazole and hydrocortisone in patients with advanced prostate carcinomaCancer, 1997
- Ketoconazole Retains Activity in Advanced Prostate Cancer Patients with Progression Despite Flutamide WithdrawalJournal of Urology, 1997
- Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm.Journal of Clinical Oncology, 1997
- Ketoconazole: A Possible Direct Cytotoxic Effect on Prostate Carcinoma CellsJournal of Urology, 1989
- Ketoconazole therapy for hormonally refractive metastatic prostate cancerUrology, 1988
- Mechanism of Inhibition of Human Testicular Steroidogenesis by Oral Ketoconazole∗Journal of Clinical Endocrinology & Metabolism, 1986
- Objective Responses to Ketoconazole Therapy in Patients with Relapsed Progressive Prostatic CancerBritish Journal of Urology, 1986
- High-dose ketoconazole therapy and adrenal and testicular function in humansArchives of internal medicine (1960), 1984
- Ketoconazole: A Novel and Rapid Treatment for Advanced Prostatic CancerJournal of Urology, 1983
- Ketoconazole blocks testosterone synthesisArchives of internal medicine (1960), 1982